A Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure
Primary Purpose
Surgical Wound
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Subcuticular suture
Subcuticular staple
Sponsored by
About this trial
This is an interventional treatment trial for Surgical Wound focused on measuring Subcuticular suture, Subcuticular staple, Skin closure, Incision closure, Wound
Eligibility Criteria
Inclusion criteria:
- Gestational age ≥ 24 weeks
- Scheduled cesarean section for any indication
- Pfannenstiel incision
- Singleton gestation
Exclusion criteria:
- Failure to consent
- Gestational age < 24 weeks
- Vaginal delivery
- Intrauterine fetal death
- Multifetal gestation
- Suspected infection, i.e. chorioamnionitis
- BMI > 50
Sites / Locations
- Mayo Clinic in Rochester
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Subcuticular suture
Subcuticular staple
Arm Description
Subcuticular suture has been used for many years to close skin incisions.
Subcuticular staples are a newer modality than suture, but are currently an accepted and widely used skin closure technique.
Outcomes
Primary Outcome Measures
Total Surgical Time, All Resident Levels
Total surgical time was defined as the time from incision start to incision completion. Measured for all resident education levels (1 to 4 years postgraduate).
Skin Closure Time, All Resident Levels
Measured for all resident education levels (1 to 4 years postgraduate).
Secondary Outcome Measures
Total Number of Participants With Postoperative Complications
Postoperative complications were assessed by chart review.
Participants With Postoperative Complications, by Type
Postoperative complications were assessed by chart review.
Postoperative Pain
Post-operative pain was assessed by pain medication use through chart review.
Number of Subjects Requiring Patient-controlled, Alternative Oral, or Single Dose IV/IM Analgesic
Post-operative pain was assessed by pain medication use through chart review. These subjects required patient-controlled analgesia, or alternative oral analgesic, or a single dose of intravenous (IV) or intramuscular (IM) analgesic. Alternative oral analgesics included hydromorphone, hydrocodone/acetaminophen, or oxycodone/acetaminophen .
Patient Satisfaction
Patient satisfaction was measured by questionnaire at the time of dismissal from the hospital and at their 6 week postpartum/postoperative exam. There were 4 questions: How satisfied are you with the appearance of your skin incision? How willing are you to recommend this same skin closure to a friend? How willing are you to have this same skin closure for your next cesarean section? What is your overall satisfaction with your surgical procedure, including the skin incision? For reporting purposes, possible answers for each item were grouped into negative (not at all, not very, or no opinion), or positive (somewhat or extremely).
Surgeon Satisfaction (Per Procedure)
Surgeon satisfaction was assessed by a 3-question questionnaire immediately after performing the procedure. The questions were: How satisfied are you with the appearance of the skin incision?" "How willing are you to recommend this skin closure (whether it was staples or suture) to a patient?" "How willing are you to use this skin closure (whether it was staples or suture) for your next cesarean section?" There were 5 possible responses to each question (not at all, not very, no opinion, somewhat, extremely), with "not at all,' "not very," and "no opinion" being a negative response, and "somewhat" and "extremely " being a positive response. Categories reported were negative, (including no opinion), and positive.
Cosmetic Outcome
The cosmetic outcome will be assessed by patients and a blinded observer at the 6 week postpartum/postoperative exam using the Patient Observer Scar Assessment Scale (POSAS). The POSAS consists of two parts: a Patient Scale and an Observer Scale. Both scales contain six items that are scored numerically. Each item of both scales has a 10-point score, with 10 indicating the worst imaginable scar or sensation. The lowest score is '1', and corresponds to the situation of normal skin (normal pigmentation, no itching etc), and goes up to the worst imaginable. Besides the six items the 'Overall Opinion' of the scar quality is scored separately of both patients and observers. Again, a 10-point scale is used in which 10 corresponds to the worst imaginable scar.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01753518
Brief Title
A Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure
Official Title
A Randomized Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure
Study Type
Interventional
2. Study Status
Record Verification Date
April 2015
Overall Recruitment Status
Completed
Study Start Date
November 2012 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
June 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Margaret L. Dow, M.D.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Currently, the way doctors close the skin during cesarean section is different between surgeons and there is little evidence to support the use of one kind of closure over the other. At the Mayo Clinic Family Birth Center, skin is currently closed using an absorbable suture (or stitch), placed within the top layer of skin. At other institutions, a metal staple is often used to close the skin.
There is a new technique that uses special absorbable staples just beneath the skin. This technology may be equal to, or possibly better than, current skin closure techniques. However, there is currently little data to show how it compares. The purpose of this study is to compare the absorbable staple to the currently used absorbable suture. The data from this study will then be used to help determine the best technique for skin closure.
Detailed Description
Cesarean section is one of the most frequently performed surgical procedures worldwide. In the United States, the proportion of deliveries by cesarean has increased from approximately 21% in 1996 to 32.8% in 2010. Ultimately, the rising incidence of cesarean delivery results in increased surgical morbidity; including pain, blood loss, and surgical site infections, which leads to an increase in overall hospitalization days and healthcare costs. This volume of surgical procedures also carries the risk of blood and body fluid exposures to surgical staff. Suture needles contribute to 43.4% of all sharps injuries in surgical settings and 51.5% of sharp injuries to surgeons alone. Additionally, it was discovered that 20% of blood borne pathogen exposures on the Mayo Clinic Rochester campus in 2011 occurred in the Department of Obstetrics and Gynecology. Therefore, any quality improvement measure regarding cesarean sections has the potential to significantly impact overall surgical morbidity, bloodborne pathogen exposure, and healthcare costs at our institution. Reviews of current literature show a lack of evidence for many of the surgical steps during cesarean procedures. Thus, there is an urgent need to define evidence-based surgical techniques for each step, from incision to closure.
The optimal skin closure technique is simple, quick, cost-effective, and provides adequate tissue approximation with a good cosmetic outcome while minimizing the risk of infection, dehiscence, and pain. Ideally, needlestick injuries would also be eliminated. It is currently unknown which skin closure method is superior with regard to these outcomes.
The INSORB 20 (Incisive Surgical) is a new, single-use device for skin closure that aims to combine the speed of a staple with the cosmetic outcome of a subcuticular suture, while eliminating the need for staple removal. Additionally, it should reduce the incidence of needlestick injury. INSORB also claims to result in a "low maintenance wound" with less surgical site infection, lower inflammation, and increased patient comfort and satisfaction. However, data is limited comparing INSORB to the current standards of care (either staples or suture).
The purpose of this study is to determine if the new absorbable subcuticular staples (INSORB) improves outcomes compared to the current standard absorbable subcuticular suture for skin closure in cesarean sections.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Wound
Keywords
Subcuticular suture, Subcuticular staple, Skin closure, Incision closure, Wound
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
220 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Subcuticular suture
Arm Type
Active Comparator
Arm Description
Subcuticular suture has been used for many years to close skin incisions.
Arm Title
Subcuticular staple
Arm Type
Active Comparator
Arm Description
Subcuticular staples are a newer modality than suture, but are currently an accepted and widely used skin closure technique.
Intervention Type
Device
Intervention Name(s)
Subcuticular suture
Other Intervention Name(s)
Monocryl
Intervention Description
subcuticular Monocryl suture closure
Intervention Type
Device
Intervention Name(s)
Subcuticular staple
Other Intervention Name(s)
Insorb
Intervention Description
subcuticular staple wound closure with INSORB 20 device
Primary Outcome Measure Information:
Title
Total Surgical Time, All Resident Levels
Description
Total surgical time was defined as the time from incision start to incision completion. Measured for all resident education levels (1 to 4 years postgraduate).
Time Frame
Measured at the time of the procedure (day 1), approximately 1 hour after incision start
Title
Skin Closure Time, All Resident Levels
Description
Measured for all resident education levels (1 to 4 years postgraduate).
Time Frame
Measured at the time of the procedure (day 1), approximately 1 hour after incision start
Secondary Outcome Measure Information:
Title
Total Number of Participants With Postoperative Complications
Description
Postoperative complications were assessed by chart review.
Time Frame
From the day of the procedure (Day 1) for 6 weeks
Title
Participants With Postoperative Complications, by Type
Description
Postoperative complications were assessed by chart review.
Time Frame
From the day of the procedure (Day 1) for 6 weeks
Title
Postoperative Pain
Description
Post-operative pain was assessed by pain medication use through chart review.
Time Frame
From day of procedure until end of hospital stay (typical dismissal on day 4)
Title
Number of Subjects Requiring Patient-controlled, Alternative Oral, or Single Dose IV/IM Analgesic
Description
Post-operative pain was assessed by pain medication use through chart review. These subjects required patient-controlled analgesia, or alternative oral analgesic, or a single dose of intravenous (IV) or intramuscular (IM) analgesic. Alternative oral analgesics included hydromorphone, hydrocodone/acetaminophen, or oxycodone/acetaminophen .
Time Frame
From day of procedure until end of hospital stay (typical dismissal on day 4)
Title
Patient Satisfaction
Description
Patient satisfaction was measured by questionnaire at the time of dismissal from the hospital and at their 6 week postpartum/postoperative exam. There were 4 questions: How satisfied are you with the appearance of your skin incision? How willing are you to recommend this same skin closure to a friend? How willing are you to have this same skin closure for your next cesarean section? What is your overall satisfaction with your surgical procedure, including the skin incision? For reporting purposes, possible answers for each item were grouped into negative (not at all, not very, or no opinion), or positive (somewhat or extremely).
Time Frame
At the time of dismissal (typically day 3 or 4) and at 6 weeks postoperative appointment
Title
Surgeon Satisfaction (Per Procedure)
Description
Surgeon satisfaction was assessed by a 3-question questionnaire immediately after performing the procedure. The questions were: How satisfied are you with the appearance of the skin incision?" "How willing are you to recommend this skin closure (whether it was staples or suture) to a patient?" "How willing are you to use this skin closure (whether it was staples or suture) for your next cesarean section?" There were 5 possible responses to each question (not at all, not very, no opinion, somewhat, extremely), with "not at all,' "not very," and "no opinion" being a negative response, and "somewhat" and "extremely " being a positive response. Categories reported were negative, (including no opinion), and positive.
Time Frame
Immediately after the procedure (day 1)
Title
Cosmetic Outcome
Description
The cosmetic outcome will be assessed by patients and a blinded observer at the 6 week postpartum/postoperative exam using the Patient Observer Scar Assessment Scale (POSAS). The POSAS consists of two parts: a Patient Scale and an Observer Scale. Both scales contain six items that are scored numerically. Each item of both scales has a 10-point score, with 10 indicating the worst imaginable scar or sensation. The lowest score is '1', and corresponds to the situation of normal skin (normal pigmentation, no itching etc), and goes up to the worst imaginable. Besides the six items the 'Overall Opinion' of the scar quality is scored separately of both patients and observers. Again, a 10-point scale is used in which 10 corresponds to the worst imaginable scar.
Time Frame
Measured at 6 week postoperative appointment
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria:
Gestational age ≥ 24 weeks
Scheduled cesarean section for any indication
Pfannenstiel incision
Singleton gestation
Exclusion criteria:
Failure to consent
Gestational age < 24 weeks
Vaginal delivery
Intrauterine fetal death
Multifetal gestation
Suspected infection, i.e. chorioamnionitis
BMI > 50
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Tessmer-Tuck, MD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic in Rochester
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
21343772
Citation
Tuuli MG, Rampersad RM, Carbone JF, Stamilio D, Macones GA, Odibo AO. Staples compared with subcuticular suture for skin closure after cesarean delivery: a systematic review and meta-analysis. Obstet Gynecol. 2011 Mar;117(3):682-690. doi: 10.1097/AOG.0b013e31820ad61e. Erratum In: Obstet Gynecol. 2011 Jun;117(6):1440.
Results Reference
background
PubMed Identifier
9592605
Citation
Jagger J, Bentley M, Tereskerz P. A study of patterns and prevention of blood exposures in OR personnel. AORN J. 1998 May;67(5):979-81, 983-4, 986-7 passim. doi: 10.1016/s0001-2092(06)62623-9.
Results Reference
background
PubMed Identifier
14520211
Citation
Jenkins TR. It's time to challenge surgical dogma with evidence-based data. Am J Obstet Gynecol. 2003 Aug;189(2):423-7. doi: 10.1067/s0002-9378(03)00587-8.
Results Reference
background
PubMed Identifier
16260200
Citation
Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery. Am J Obstet Gynecol. 2005 Nov;193(5):1607-17. doi: 10.1016/j.ajog.2005.03.063.
Results Reference
background
PubMed Identifier
20216417
Citation
Walsh CA. Evidence-based cesarean technique. Curr Opin Obstet Gynecol. 2010 Apr;22(2):110-5. doi: 10.1097/GCO.0b013e3283372327.
Results Reference
background
Learn more about this trial
A Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure
We'll reach out to this number within 24 hrs